Non-compliance on the part of the professional community with a national guideline: An argumentative policy analysis

Health Policy - Tập 78 - Trang 353-359 - 2006
Margriet Moret-Hartman1, Pieter D. Knoester2, Yechiel A. Hekster2, Gert Jan van der Wilt1
1Department of Medical Technology Assessment, Nijmegen University Medical Centre, NL-6500 HB Nijmegen, The Netherlands
2Department of Clinical Pharmacy, Nijmegen University Medical Center, Nijmegen, The Netherlands

Tài liệu tham khảo

Lindblom, 1992

Netherlands Court of Audit. Between policy and implementation: lessons from a recent inquiry of the Court of Audit. The Hague, SDU 2003 (in Dutch: Dutch Parliament, Dossier 28 831, nrs. 1-2).

Trouiller, 2002, Drug development for neglected diseases: a deficient market and a public-health policy failure, Lancet, 359, 2188, 10.1016/S0140-6736(02)09096-7

1993

Majone, 1989

Schön, 1983

Schön, 1994

Grin, 1998, From top-down, viewing policy bottom-up: the argumentative term and the coming into effect of policy instruments (in Dutch)

Tuinder S, Knoester P, Deckers C, van der Wilt GJ, Keyser A, Renier W, et al. Treatment protocols from a cost-saving perspective. A survey among neurologists. Medisch Contact 2004 (in Dutch).

Grin, 1997

Kaplan, 2004, Reproductive health effects and teratogenicity of antiepileptic drugs, Neurology, 63, S13, 10.1212/WNL.63.10_suppl_4.S13

Black, 1996, Why we need observational studies to evaluate the effectiveness of health care, British Medical Journal, 312, 1215, 10.1136/bmj.312.7040.1215

Tunis, 2003, Increasing the value of clinical research for decision making in clinical and health policy, The Journal of the American Medical Association, 290, 1624, 10.1001/jama.290.12.1624

Sackett, 1991

Derry, 2001, Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials, Biomedical Chromatography, 1

Thông tin
Thông tin xuất bản

Health Policy

Tập 78

353-359

Thông tin tác giả